493 related articles for article (PubMed ID: 17047528)
1. Vasoactive drug support in septic shock.
Dries DJ
Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
[No Abstract] [Full Text] [Related]
2. Recommendations for the treatment of patients with septic shock.
Meier-Hellmann A; Reinhart K
Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
[No Abstract] [Full Text] [Related]
3. Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants.
Tourneux P; Rakza T; Abazine A; Krim G; Storme L
Acta Paediatr; 2008 Feb; 97(2):177-80. PubMed ID: 18177443
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin in septic shock: clinical equipoise mandates a time for restraint.
Russell JA
Crit Care Med; 2003 Nov; 31(11):2707-9. PubMed ID: 14605551
[No Abstract] [Full Text] [Related]
5. [Basic principles of the therapy of shock].
Schröder R
Minerva Med; 1972 Dec; 63(93):5243-6. PubMed ID: 4646406
[No Abstract] [Full Text] [Related]
6. Adrenergic support in septic shock: a critical review.
Póvoa P; Carneiro AH
Hosp Pract (1995); 2010 Feb; 38(1):62-73. PubMed ID: 20469626
[TBL] [Abstract][Full Text] [Related]
7. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
[TBL] [Abstract][Full Text] [Related]
8. Inotrope and vasopressor therapy of septic shock.
Hollenberg SM
Crit Care Nurs Clin North Am; 2011 Mar; 23(1):127-48. PubMed ID: 21316572
[TBL] [Abstract][Full Text] [Related]
9. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
10. Use of vasopressors in the treatment of cardiac arrest.
Smith MA
Crit Care Nurs Clin North Am; 2005 Mar; 17(1):71-5, xi. PubMed ID: 15749405
[TBL] [Abstract][Full Text] [Related]
11. Inotrope and vasopressor therapy of septic shock.
Hollenberg SM
Crit Care Clin; 2009 Oct; 25(4):781-802, ix. PubMed ID: 19892253
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the effects of dobutamine and dopamine in septic shock].
Régnier B; Safran D; Carlet J; Simoneau G; Rapin M
Ann Anesthesiol Fr; 1978; 19(10):859-62. PubMed ID: 35059
[TBL] [Abstract][Full Text] [Related]
13. Vasopressor use in septic shock: an update.
Leone M; Martin C
Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
[TBL] [Abstract][Full Text] [Related]
14. Dopamine compared with dobutamine in experimental septic shock: relevance to fluid administration.
Vincent JL; Van der Linden P; Domb M; Blecic S; Azimi G; Bernard A
Anesth Analg; 1987 Jun; 66(6):565-71. PubMed ID: 3578867
[TBL] [Abstract][Full Text] [Related]
15. [Use of dobutamine in the treatment of septic shock].
Dupeyron JP; Pottecher T; Haberer JP; Gauthier-Lafaye JP
Anesth Analg (Paris); 1977; 34(5):917-27. PubMed ID: 26294
[No Abstract] [Full Text] [Related]
16. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
Russell JA; Lee T; Singer J; De Backer D; Annane D
J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
[TBL] [Abstract][Full Text] [Related]
17. Effect of dopamine and metaraminol on the renal function of patients with septic shock.
Hou LC; Li SZ; Xiong LZ; Chen SY; Chen M; Zhang XJ; Huo TT; Wang Q; Wang YL; Hu WN
Chin Med J (Engl); 2007 Apr; 120(8):680-3. PubMed ID: 17517184
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic interventions in resuscitation.
Boike SC; Rybak MJ
Emerg Med Clin North Am; 1983 Dec; 1(3):553-69. PubMed ID: 6396072
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin in septic shock.
Russell JA
Crit Care Med; 2007 Sep; 35(9 Suppl):S609-15. PubMed ID: 17713417
[No Abstract] [Full Text] [Related]
20. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
